Simon Freedman Email

Head Business & Therapy Development . Implantica

Current Roles

Employees:
77
Revenue:
$0
About
Implantica is a MedTech group dedicated to bringing advanced technology into the body. \n\nImplantica’s lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. \n\nImplantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energizing platform designed to power remote-controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.
Implantica Address

Zug, null
Switzerland
Implantica Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.